TY - JOUR
T1 - Prenatal whole exome sequencing detects a new homozygous fukutin (FKTN) mutation in a fetus with an ultrasound suspicion of familial Dandy–Walker malformation
AU - Traversa, Alice
AU - Bernardo, Silvia
AU - Paiardini, Alessandro
AU - Giovannetti, Agnese
AU - Marchionni, Enrica
AU - Genovesi, Maria Luce
AU - Guadagnolo, Daniele
AU - Torres, Barbara
AU - Paolacci, Stefano
AU - Bernardini, Laura
AU - Mazza, Tommaso
AU - Carella, Massimo
AU - Caputo, Viviana
AU - Pizzuti, Antonio
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Background: Posterior fossa malformations are among the most diagnosed central nervous system (CNS) anomalies detected by ultrasound (US) in prenatal age. We identified the pathogenic gene mutation in a male fetus of 17 weeks of gestation with US suspicion of familial Dandy–Walker spectrum malformation, using Next Generation Sequencing approach in prenatal diagnosis. Methods: Whole exome sequencing (WES) approach has been performed on fetal genomic DNA. After reads preprocessing, mapping, variant calling, and annotation, a filtering strategy based on allelic frequency, recessive inheritance, and phenotypic ontologies has been applied. A fetal magnetic resonance imaging (MRI) at 18 weeks of gestation has been performed. An in silico analysis of a potential causative missense variant in the fukutin protein has been carried out through a structural modeling approach. Results: We identified a new homozygous missense mutation in fukutin gene (FKTN, NM_006731.2: c.898G>A; NP_006722.2: p.Gly300Arg). Fetal MRI supported molecular findings. Structural modeling analyses indicated a potential pathogenetic mechanism of the variant, through a reduced activation of the sugar moieties, which in turn impairs transfer to dystroglycan and thus its glycosylation. These findings pointed to a redefinition of the US suspicion of recurrence of Dandy–Walker malformation (DWM) to a muscular dystrophy-dystroglycanopathy type A4. Conclusions: The present case confirmed WES as a reliable tool for the prenatal identification of the molecular bases of early-detected CNS malformations.
AB - Background: Posterior fossa malformations are among the most diagnosed central nervous system (CNS) anomalies detected by ultrasound (US) in prenatal age. We identified the pathogenic gene mutation in a male fetus of 17 weeks of gestation with US suspicion of familial Dandy–Walker spectrum malformation, using Next Generation Sequencing approach in prenatal diagnosis. Methods: Whole exome sequencing (WES) approach has been performed on fetal genomic DNA. After reads preprocessing, mapping, variant calling, and annotation, a filtering strategy based on allelic frequency, recessive inheritance, and phenotypic ontologies has been applied. A fetal magnetic resonance imaging (MRI) at 18 weeks of gestation has been performed. An in silico analysis of a potential causative missense variant in the fukutin protein has been carried out through a structural modeling approach. Results: We identified a new homozygous missense mutation in fukutin gene (FKTN, NM_006731.2: c.898G>A; NP_006722.2: p.Gly300Arg). Fetal MRI supported molecular findings. Structural modeling analyses indicated a potential pathogenetic mechanism of the variant, through a reduced activation of the sugar moieties, which in turn impairs transfer to dystroglycan and thus its glycosylation. These findings pointed to a redefinition of the US suspicion of recurrence of Dandy–Walker malformation (DWM) to a muscular dystrophy-dystroglycanopathy type A4. Conclusions: The present case confirmed WES as a reliable tool for the prenatal identification of the molecular bases of early-detected CNS malformations.
KW - Dandy–Walker malformation
KW - fetal imaging
KW - FKTN
KW - muscular dystrophy-dystroglycanopathy type A4
KW - prenatal diagnosis
KW - whole exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85075459805&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075459805&partnerID=8YFLogxK
U2 - 10.1002/mgg3.1054
DO - 10.1002/mgg3.1054
M3 - Article
AN - SCOPUS:85075459805
SN - 2324-9269
JO - Molecular genetics & genomic medicine
JF - Molecular genetics & genomic medicine
M1 - e1054
ER -